Kairos Pharma Cash Flow Statement (2024-2025) | KAPA

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Operating Activities
Net Income -0.30M-0.23M-0.92M-1.58M-1.26M-1.42M
Cash from Operations 0.04M-0.17M-2.02M-1.80M-0.71M-0.81M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.04M0.02M0.12M0.01M0.04M0.04M
Change in Working Capital
Change in Accured Expenses 0.31M0.02M-0.19M0.26M-0.19M-0.13M
Other Working Capital Changes 0.01M-0.00M-0.01M0.03M0.02M0.03M
Financing Activities
Other financing activities 0.09M-0.05M0.35M
Cash from Financing Activities -0.09M0.15M5.22M-0.14M3.06M0.22M
Additional items
Change in Cash -0.05M-0.02M3.20M-1.95M2.34M-0.58M
Free Cash Flow 0.04M-0.17M-2.02M-1.80M-0.71M-0.81M
Net Cash Flow -0.05M-0.02M3.20M-1.95M2.34M-0.58M